| Identification | Back Directory | [Name]
N-[3-(1-Cyano-1-methylethyl)-5-(4-methyl-1H-imidazol-1-yl)phenyl]-2-fluoro-4-methyl-5-[2-[8-[(1-methyl-1H-pyrazol-4-yl)amino]imidazo[1,2-a]pyridin-3-yl]ethynyl]benzamide | [CAS]
2699634-21-2 | [Synonyms]
| [Molecular Formula]
C35H30FN9O | [MOL File]
2699634-21-2.mol | [Molecular Weight]
611.67 |
| Hazard Information | Back Directory | [Uses]
BCR-ABL kinase-IN-3 (example 1) is a potent inhibitor of BCR-ABL that plays an important role in acute myeloid leukemia (AML) research[1]. | [References]
[1] Lee Doohyun, et al. Preparation of 3-((8-((1H-pyrazol-4-yl)amino)imidazo[1,2-a]pyridin-3-yl)ethynyl)-N-phenylbenzamide derivatives for prevention or treatment of cancer. World Intellectual Property Organization, WO2021172931 A1 2021-09-02 |
|
|